Evaluation of Saroglitazar's Effects on Small Dense LDL and Non-HDL Cholesterol Particles in Diabetic Dyslipidemia Patients

被引：0
|
作者：
Dinkar, Jyoti
Ranjan, Rajeev
Chandra, Abhishek
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-7-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
7-OR
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients
    Soran, Handrean
    France, Michael W.
    Kwok, See
    Dissanayake, Sanjaya
    Charlton-Menys, Valentine
    Younis, Nahla N.
    Durrington, Paul N.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 566 - 571
  • [42] Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients
    Caixas, A
    OrdonezLlanos, J
    deLeiva, A
    Payes, A
    Homs, R
    Perez, A
    DIABETES, 1997, 46 (07) : 1207 - 1213
  • [43] Low HDL-cholesterol is associated with small dense LDL in coronary heart disease patients but not in patients with apoA-I defects
    Wessling, J
    Schulte, H
    Assmann, G
    Miccoli, R
    Navalesi, R
    vonEckardstein, A
    ATHEROSCLEROSIS, 1997, 129 (01) : 33 - 33
  • [44] Effect of Prescription Omega-3 Fatty Acids on Non-HDL Cholesterol (Stratified by Baseline LDL-Cholesterol Level) in Statin-Treated Patients with Hypertriglyceridemia
    Maki, Kevin C.
    Davidson, Michael H.
    Doyle, Ralph T.
    Ballantyne, Christie M.
    CIRCULATION, 2009, 119 (10) : E333 - E333
  • [45] Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring effective reductions in cholesterol using rosuvastatin therapY (MERCURY) II
    Ballantyne, Christie M.
    Bertolami, Marcelo
    Garcia, Rugo Ricardo Hernandez
    Nul, Daniel
    Stein, Evan A.
    Theroux, Pierre
    Weiss, Robert
    Cain, Valerie A.
    Raichlen, Joel S.
    AMERICAN HEART JOURNAL, 2006, 151 (05) : 975.e1 - 975.e9
  • [46] Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease
    Vaverkova, Helena
    Farnier, Michel
    Averna, Maurizio
    Missault, Luc
    Viigimaa, Margus
    Dong, Qian
    Shah, Arvind
    Johnson-Levonas, Amy O.
    Brudi, Philippe
    CLINICAL BIOCHEMISTRY, 2011, 44 (8-9) : 627 - 634
  • [47] Influence of BMI and HbA1c on cardiovascular risk factors: LDL cholesterol and non HDL cholesterol in type 2 diabetic patients
    Disoteo, O.
    Pizzi, G. L.
    Zanni, D.
    Fossati, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 114 - 114
  • [48] High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy
    Hirano, T
    Naito, H
    Kurokawa, M
    Ebara, T
    Nagano, S
    Adachi, M
    Yoshino, G
    ATHEROSCLEROSIS, 1996, 123 (1-2) : 57 - 72
  • [49] Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia
    Gentile, Marco
    Calcaterra, Ilenia
    Strazzullo, Alfonso
    Pagano, Carmen
    Pacioni, Delia
    Speranza, Enza
    Rubba, Paolo
    Marotta, Gennaro
    CLINICAL LIPIDOLOGY, 2015, 10 (06) : 475 - 480
  • [50] Comparative evaluation of LDL-CT, non-HDL/HDL ratio, and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitus
    Paunica, Ioana
    Mihai, Andrada Doina
    Stefan, Simona
    Pantea-Stoiana, Anca
    Serafinceanu, Cristian
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (12)
12345